Medical Blog About Treatment Abroad

According to official statistics from the WHO in 2022, oncological diseases are now the cause of one in every six deaths worldwide. This has encouraged the international medical community to develop new advanced stage 4 cancer treatment methods and increase the effectiveness of the already existing ones.

Cervical cancer is ranked as the fourth most common cancer among women. Nearly 660,000 new patients were diagnosed in 2022, with 350,000 deaths reported. Most of those lethal cases, about 94%, are observed in low- and middle-income countries because of limited access to human papillomavirus (HPV) vaccination and regular screenings.

Ovarian cancer is the eighth most common cancer among women, with approximately 324,603 new cases just in 2022 alone. It represents a global health concern with over 206,000 related deaths. Thanks to the fact that the disease often presents with general symptoms, there are many cases diagnosed in the later stages.

No reliable symptoms can be found in the early stages of lung cancer; most patients receive their diagnosis after the disease has already progressed — which is not a failure of medicine but a consequence of biology that screening exists specifically to interrupt. In Germany alone, approximately 56,700 new cases...

Thyroid cancer is one of the most rapidly growing endocrine malignancies worldwide. In Europe, the annual incidence reaches 8.3 cases per 100,000 population, while the mortality remains relatively low at 0.33 per 100,000. This is now possible thanks to modern diagnostic tools and advanced treatment options.

When liver cancer is diagnosed late — which it most often is, because the disease produces no reliable symptoms until it has already progressed — the treatment decisions that follow are not theoretical. In 2020, approximately 905,700 new cases were recorded globally and around 830,200 people died from...

When the treatment a patient needs is unavailable or inadequately performed at home, the question of where to go becomes urgent. Germany has become one of the most consistent answers — not because of reputation alone, but because of what that reputation is built on: cutting-edge technology, professional health care...

The reality drives the urgent need for novel and more effective astrocytoma treatments. Astrocytoma group of neoplasms includes relatively slow-growing grades I–III and grade IV – glioblastoma, mentioned among the most lethal cancers. In the U.S., gliomas strike roughly 6 per 100,000 people annually. That is, each year, about...